iaea.org

Urea Breath Test for Helicobacter Pylori infection

This e-learning module gives an overview of the carbon-13 urea breath test (13 C-UBT) for Helicobacter pylori (H. pylori) infection. It describes a robust test for the diagnosis of gastric H. pylori ...
Medscape

13C-Urea Breath Test: Reproducibility and Association With the Severity of Helicobacter pylori-associated Antral Gastritis

Asymptomatic Subjects. Sixty-five healthy, asymptomatic volunteers aged 54.2 ± 2.0 years (mean ± SEM; range 20 86 years) were involved in the present study. All subjects were initially screened for H.
Medscape

Simplified 13C-Urea Breath Test With a New Infrared Spectrometer for Diagnosis of Helicobacter pylori Infection

Tseng-Shing Chen, Full-Young Chang, Pang-Chi Chen, Thomas W Huang, Jonathan T Ou, Ming-Hung Tsai, Ming-Shiang Wu, Jaw-Town Lin ...
Becker's ASC

Gastroenterology technology company to know: Exalenz Bioscience

Exalenz Bioscience’s flagship product is the BreathID® Hp test, a non-invasive urea in-office breath test designed to detect active H. pylori infections within minutes. Clinical studies have ...
Labroots

Implementation of Helicobacter Pylori Stool Antigen Testing in a Large Metropolitan Center: A Prospective Comparative Diagnostic Trial

Background: Clinical guidelines for H. pylori screening and post-treatment testing endorse the use of urea breath test (UBT), H. pylori stool antigen test (HpSAT), and biopsy-related tests. Due to ...
Nasdaq

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.

CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a ...
Nasdaq

Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform

CINCINNATI and MODIIN, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies have entered ...
Business Wire

Exalenz Bioscience Adds The George Washington University Department of Emergency Medicine to Its Expanding Roster of U.S. Customers

WILMINGTON, Del.--(BUSINESS WIRE)--Exalenz Bioscience, Inc., a provider of breath testing equipment for the diagnosis and management of digestive system and liver conditions, today announced the ...